Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06339034 · ClinicalTrials.gov registry record · Phase 1

Repurposing Lithium for Parkinson's Disease: a RCT

A Phase 1 study of Parkinson Disease, sponsored by State University of New York at Buffalo.

Active
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT06339034 is a Phase 1 study of Parkinson Disease that is active but no longer recruiting, run by State University of New York at Buffalo. The registered enrollment target is 20 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06339034, a Phase 1 study of Parkinson Disease, is active but no longer recruiting, sponsored by State University of New York at Buffalo.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.

Conditions Studied

Parkinson Disease

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Lithium

Study Locations (1)

New York

  • UBMD Neurology - Williamsville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-07-03
Est. Completion 2026-02
Phase Phase 1

Sponsor

State University of New York at Buffalo

243 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06339034

The ClinicalTrials.gov registry entry for NCT06339034 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06339034 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06339034 about?

NCT06339034 is a clinical study titled "Repurposing Lithium for Parkinson's Disease: a RCT". This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.

What is the current status of trial NCT06339034?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2024-07-03. Estimated completion is 2026-02.

What conditions does trial NCT06339034 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06339034?

The interventions under investigation include: Placebo (OTHER), Lithium (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06339034?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06339034 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.